COMPANY

EIT Pharma

HQ: Kirkland, WA source · eitpharma.com ↗ · West Coast

Our lead assets are being developed as treatments for Hepatitis D and Acute Respiratory Infection (ARI). From company website Source · Oct 12, 2026

Keywords: hepatitis D

Location: Kirkland, WA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series A · $35M · announced Aug 31, 2026 Company release ↗
Source quote
- Aug 31, 2026 · Company release ↗
  “(“EIT Pharma” or the “Company”), a biotechnology company focused on developing therapies for infectious diseases, today announced the successful close of an oversubscribed $35 million Series A financing round.”

Raises announced in these releases: $35M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Aug 31, 2026 Raise Private equity round — Series A: $35M (total, as published), announced Aug 31, 2026. Source: company's own press page. source ↗
Aug 31, 2026 Raise Series A · $35M source ↗

Raised: $35.0M. Last 2 years.

Aug 31, 2026 Private equity round — Series A: $35M (total, as published), announced Aug 31, 2026. Source: company's own press page. source ↗